Telemedicine

In a significant move poised to reshape the digital health landscape, the U.S. Food and Drug Administration has officially recalibrated its approach to regulatory oversight for a rapidly expanding category of consumer technology. The agency recently issued new guidance that effectively limits its

The rapid expansion of platform-based telehealth has created a significant legal gray area where technological convenience clashes directly with state-specific professional regulations, leaving practitioners to navigate a complex and high-stakes compliance landscape. For Physician Assistants (PAs)

The subtle nuances in a person's voice, once the domain of human intuition, are now being decoded by artificial intelligence to predict and monitor serious medical conditions across a rapidly evolving European digital health sector. This emerging market for voice and vocal biomarkers, which focuses

The modern healthcare landscape is undergoing a seismic shift, fundamentally driven by the practical integration of artificial intelligence and an explosion of interconnected medical devices. AI is no longer a theoretical pursuit but a tangible clinical asset, actively accelerating diagnoses,

The intricate and often fragmented landscape of the American healthcare system is undergoing a profound transformation, driven not by policy alone but by a surge of technological innovation backed by substantial venture capital. Recent funding announcements totaling over $427 million underscore a

In a move that brought both widespread relief and sharp criticism across the healthcare industry, the Drug Enforcement Administration (DEA) once again extended crucial telehealth prescribing flexibilities for controlled substances, narrowly averting a crisis for countless patients dependent on